InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Avalo Therapeutics, Inc.

AVTX Clue Score19
United States Fiscal year ends December CIK 0001534120 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Mitchell Chan
6 May 2026
Director
Sold on a plan
3,167
$22.88
$72.46K
Christopher Ryan Sullivan
30 Apr 2026
Chief Financial Officer
Sold on a plan
8,457
$13.23
$111.85K
Christopher Ryan Sullivan
29 Apr 2026
Chief Financial Officer
Sold on a plan
8,458
$13.09
$110.74K
Christopher Ryan Sullivan
2 Apr 2026
Chief Financial Officer
Sold on a plan
1,780
$17.57
$31.27K
Christopher Ryan Sullivan
2 Apr 2026
Chief Financial Officer
Sold on a plan
6,200
$17.02
$105.55K
Christopher Ryan Sullivan
1 Apr 2026
Chief Financial Officer
Sold on a plan
7,479
$16.83
$125.84K
Christopher Ryan Sullivan
1 Apr 2026
Chief Financial Officer
Sold on a plan
500
$15.86
$7.93K
Show all 43 transactions →

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 35
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 777,657
History held since 20 Oct 2015